US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
CVR Partners LP
NYSE:UAN
CVR Partners LP
Cash & Cash Equivalents
CVR Partners LP
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CVR Partners LP
NYSE:UAN
|
Cash & Cash Equivalents
$45.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-6%
|
|
CF Industries Holdings Inc
NYSE:CF
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
23%
|
CAGR 5-Years
18%
|
CAGR 10-Years
-8%
|
|
FMC Corp
NYSE:FMC
|
Cash & Cash Equivalents
$417.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
31%
|
CAGR 10-Years
16%
|
|
Corteva Inc
NYSE:CTVA
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Scotts Miracle-Gro Co
NYSE:SMG
|
Cash & Cash Equivalents
$65.1m
|
CAGR 3-Years
65%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-8%
|
|
Mosaic Co
NYSE:MOS
|
Cash & Cash Equivalents
$336.7m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-18%
|
See Also
What is CVR Partners LP's Cash & Cash Equivalents?
Cash & Cash Equivalents
45.3m
USD
Based on the financial report for Mar 31, 2024, CVR Partners LP's Cash & Cash Equivalents amounts to 45.3m USD.
What is CVR Partners LP's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-6%
Over the last year, the Cash & Cash Equivalents growth was -63%. The average annual Cash & Cash Equivalents growth rates for CVR Partners LP have been -5% over the past three years , -14% over the past five years , and -6% over the past ten years .